The following pages link to (Q3835342):
Displaying 26 items.
- On probabilistic certification of combined cancer therapies using strongly uncertain models (Q739722) (← links)
- New developments in the application of optimal control theory to therapeutic protocols (Q905822) (← links)
- Optimal control for a cancer chemotherapy problem with general growth and loss functions (Q908872) (← links)
- Role of optimal control theory in cancer chemotherapy (Q915680) (← links)
- A kinetic study of chemotherapy (Q1053634) (← links)
- Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer (Q1712868) (← links)
- The combined effects of optimal control in cancer remission (Q1732198) (← links)
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors (Q1743540) (← links)
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers (Q1790751) (← links)
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis (Q1794472) (← links)
- Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity (Q1804872) (← links)
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy (Q1862197) (← links)
- Stochastic optimal therapy for enhanced immune response (Q1886329) (← links)
- On the role of the objective in the optimization of compartmental models for biomedical therapies (Q2025280) (← links)
- On the role of pharmacometrics in mathematical models for cancer treatments (Q2026619) (← links)
- Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach (Q2120664) (← links)
- Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach (Q2131714) (← links)
- Optimization of interleukin-21 immunotherapeutic strategies (Q2211591) (← links)
- On the role of tumor heterogeneity for optimal cancer chemotherapy (Q2328346) (← links)
- Numerical optimal control of a size-structured PDE model for metastatic cancer treatment (Q2328437) (← links)
- Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy (Q2422280) (← links)
- Optimal control for a mathematical model for chemotherapy with pharmacometrics (Q5001339) (← links)
- Robust feedback design for combined therapy of cancer (Q5408038) (← links)
- (Q5860569) (← links)
- The impact of radio-chemotherapy on tumour cells interaction with optimal control and sensitivity analysis (Q6539724) (← links)
- Optimal control for biphasic chemotaxis model of tumour growth under chemotherapy (Q6564752) (← links)
